⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11470445 | 0.94 | — | — | |
| SCHEMBL204690 | 0.67 | — | — | |
| SCHEMBL203882 | 0.64 | MEN1 (0.38) | — | |
| SCHEMBL5586253 | 0.64 | — | — | |
| SCHEMBL254201 | 0.64 | MEN1 (0.38) | — | |
| SCHEMBL31125 | 0.64 | — | — | |
| SCHEMBL12239869 | 0.62 | — | — | |
| SCHEMBL499994 | 0.62 | — | — | |
| SCHEMBL201927 | 0.62 | — | — | |
| Hydrochloric Acid SCHEMBL738325 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6544592-B1 | For producing crosslinked film | STAHL INTERNATIONAL B.V. (NL) | 2003-04-08 | — | — | US | claimed |
| US-6172022-B1 | DETERGENT COMPOSITION COMPRISING ALKALI METAL AND MAGNESIUM SALTS OF LINEAR ALKYLBENZENESULFONATE, ETHOXYLATED ALKYL ETHER SULFATE, ALKYL POLYGLUCOSIDE, POLYOXYETHYLENEDIAMINE, AMINE OXIDE AND/OR FATTY ACID MONOALKANOLAMIDE, WATER | COLGATE-PALMOLIVE COMPANY | 2001-01-09 | — | — | US | claimed |
| US-4847380-A | High molecular weight polyalkoxyamide, urea or urethane-containing piperidine radical | TEXACO INC. (US) | 1989-07-11 | — | — | US | claimed |
| US-20230323434-A1 | GENERATING CAPTURE PROBES FOR SPATIAL ANALYSIS | 10X GENOMICS, INC. | 2023-10-12 | — | — | US | disclosed |
| US-20230192607-A1 | TRANSCRIPTIONAL ENHANCED ASSOCIATE DOMAIN (TEAD) TRANSCRIPTION FACTOR INHIBITORS AND USES THEREOF | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2023-06-22 | — | — | US | disclosed |
| WO-2021133896-A1 | TRANSCRIPTIONAL ENHANCED ASSOCIATE DOMAN (TEAD) TRANSCRIPTION FACTOR INHIBITORS AND USES THEREOF | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2021-07-01 | — | — | WO | disclosed |
| WO-2021097240-A1 | COMPOUNDS AND USES THEREOF | YUMANITY THERAPEUTICS, INC. (US) | 2021-05-20 | — | — | WO | disclosed |
| WO-2020154571-A1 | COMPOUNDS AND USES THEREOF | YUMANITY THERAPEUTICS, INC. (US) | 2020-07-30 | — | — | WO | disclosed |
| WO-2019183587-A1 | COMPOUNDS AND USES THEREOF | YUMANITY THERAPEUTICS, INC. (US) | 2019-09-26 | — | — | WO | disclosed |
| US-9856254-B2 | Alkoxy substituted imidazoquinolines | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2018-01-02 | — | — | US | disclosed |
| EP-3184527-A1 | 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL | Hydra Biosciences, Inc. (US) | 2017-06-28 | — | — | EP | disclosed |
| US-20150265534-A1 | NANOSUSPENSION OF A POORLY SOLUBLE DRUG VIA MICROFLUIDIZATION PROCESS | AMGEN INC. | 2015-09-24 | — | — | US | disclosed |
| US-20150031659-A1 | 1,3,4-OXADIAZOLE AND 1,3,4-THIADIAZOLE BETA-LACTAMASE INHIBITORS | MERCK SHARP & DOHME CORP. | 2015-01-29 | — | — | US | disclosed |
| US-8871782-B2 | Alkoxy substituted imidazoquinolines | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2014-10-28 | — | — | US | disclosed |
| US-20130217626-A1 | Novel Bioactive Protein Isolated From Chinese Yam and Uses Thereof | THE UNIVERSITY OF HONG KONG (CN) | 2013-08-22 | — | — | US | disclosed |
| US-20130064843-A1 | Identification of conserved peptide blocks in homologous polypeptides | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2013-03-14 | — | — | US | disclosed |
| EP-1730152-B1 | TETRAHYDROQUINOLINE DERIVATIVES AND A PROCESS FOR PREPARING THE SAME | MITSUBISHI TANABE PHARMA CORP (JP) | 2012-05-02 | — | — | EP | disclosed |
| EP-2141163-A1 | Substituted thiazolidinones, their production and utilisation as medicine | Bayer Schering Pharma AG (DE) | 2010-01-06 | — | — | EP | disclosed |
| US-20070060754-A1 | Alkoxy substituted imidazoquinolines | 3M INNOVATIVE PROPERTIES COMPANY | 2007-03-15 | — | — | US | disclosed |
| US-4239635-A | METAL WORKING FLUIDS | CINCINNATI MILACRON INC. (US) | 1980-12-16 | — | — | US | disclosed |